References
- Heinen F, Desloovere K, Schroeder AS, et al. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Eur J Pediatr Neurol 2010;14:45–66
- Winter DA, Sidwall HG, Hobson DA. Measurement and reduction of noise in kinematics of locomotion. J Biomech 1974;7:157–9
- Molenaers G, Desloovere K, Fabry G, De Cock P. The effects of quantitative gait assessment and botulinum toxin A on musculoskeletal surgery in children with cerebral palsy. J Bone Joint Surg 2006;88:161–70
- Nolan KW, Cole LL, Liptak GS. Use of botulinum toxin type A in children with cerebral palsy. Phys Ther 2006;86:573–84
- Andersson C, Mattsson E. Adults with cerebral palsy: a survey describing problems, needs, and resources, with special emphasis on locomotion. Dev Med Child Neurol 2001;43:76–82
- Opheim A, Jahnsen R, Olsson E, Stanghelle JK. Walking function, pain, and fatigue in adults with cerebral palsy: a 7-year follow-up study. Dev Med Child Neurol 2009;51:381–8
- Maanum G, Jahnsen R, Stanghelle JK, et al. Face and construct validity of the Gait Deviation Index in adults with spastic cerebral palsy. J Rehabil Med 2012;44:272–5
- Schwartz MH, Rozumalski A. The gait deviation index: A new comprehensive index of gait pathology. J Pediatr Orthoped 2008;28:351–7
- Cardoso E, Rodrigues B, Lucena R, et al. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis. Arquivos de Neuro-Psiquiatria 2005;63:30–3
- Kadaba MP, Ramakrishnan HK, Wootten ME. Measurement of lower extremity kinematics during devel walking. J Orthopaed Res 1990;8:383–92
- Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3-dimensional motion analysis study. Gait Posture 1996;4:269–79
- Wissel J, Heinen F, Schenkel A, et al. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of “high-dose” versus “low-dose” treatment. Neuropediatrics 1999;30:120–4
- Mackey A, Walt S, Stott NS. Botulinum toxin type A in ambulant children with cerebral palsy: review. Physiotherapy 2003;89, 4:219–32
- Maanum G, Jahnsen R, Stanghelle JK, et al. Effects of Botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo-controlled trial. J Rehabil Med 2011;43:338–47